Novartis (LON:0QLR) (NYSE:NVS) (SIX:NOVN) said its experimental antibody ianalumab, used in combination with eltrombopag, ...

Novartis drew heightened retail chatter on Monday amid reports that Swiss ministers plan to meet this week with top ...

Currently exempt from US tariffs, pharmaceutical manufacturers fear steep surcharges, as promised by the US president on ...

The Swiss government is due to meet this week with pharmaceuticals firms that U.S. President Donald Trump has asked to lower ...

If approved, Novartis' ianalumab would become the first targeted treatment for patients with Sjögren’s disease.

Roche (RHHBY) and Novartis (NVS) are scheduled to meet with Swiss officials this week amid U.S. tariff threats on pharma ...

European shares ticked lower on Monday, as investors refrained from making big bets ahead of an eventful week packed with ...

The Swiss government is engaging with pharma companies Roche and Novartis to address U.S. President Trump's demand for price cuts and to negotiate a 39% tariff on Swiss exports. The discussion follows ...

We don’t see a recession in Switzerland at all,' said Jean Dalbard of Economics. 'The economy is not roaring, but it’s still growing.' ...

The additional investments in the US will not lead to a reduction in jobs in Switzerland. This is according to pharmaceutical giant Roche, which expects the number of employees to remain stable in the ...

Switzerland’s government has reached out to local drugmakers Roche Holding AG and Novartis AG to discuss the tariff situation ...

After offering congratulations for Switzerland’s national holiday the following day, Trump hit Keller-Sutter with an ...